74 related articles for article (PubMed ID: 2084715)
1. [The niacin test in schizophrenia].
Weterle R; Rybakowski J
Psychiatr Pol; 1990; 24(2):116-20. PubMed ID: 2084715
[TBL] [Abstract][Full Text] [Related]
2. [The Rorschach test in the diagnosis of schizophrenia].
Zaniecka M; Rybakowski J
Psychiatr Pol; 1989; 23(4):300-6. PubMed ID: 2631129
[TBL] [Abstract][Full Text] [Related]
3. Test-retest stability of the oral niacin test and electrodermal activity in patients with schizophrenia.
Nilsson BM; Hultman CM; Ekselius L
Prostaglandins Leukot Essent Fatty Acids; 2009; 81(5-6):367-72. PubMed ID: 19864122
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of secondary depression in schizophrenia.
Becker RE; Colliver JA; Verhulst SJ
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):4-8. PubMed ID: 4055721
[TBL] [Abstract][Full Text] [Related]
5. The niacin skin flush test in schizophrenia: a replication study.
Puri BK; Easton T; Das I; Kidane L; Richardson AJ
Int J Clin Pract; 2001; 55(6):368-70. PubMed ID: 11501224
[TBL] [Abstract][Full Text] [Related]
6. Niacin skin-flush response and electrodermal activity in patients with schizophrenia and healthy controls.
Nilsson BM; Hultman CM; Wiesel FA
Prostaglandins Leukot Essent Fatty Acids; 2006 May; 74(5):339-46. PubMed ID: 16600583
[TBL] [Abstract][Full Text] [Related]
7. Phospholipid membrane abnormalities and reduced niacin skin flush response in schizophrenia.
Buretić-Tomljanović A; Giacometti J; Nadalin S; Rubesa G; Vulin M; Tomljanović D
Psychiatr Danub; 2008 Sep; 20(3):372-83. PubMed ID: 18827766
[TBL] [Abstract][Full Text] [Related]
8. Niacin skin flush test: a research tool for studying schizophrenia.
Nadalin S; Buretić-Tomljanović A; Rubesa G; Tomljanović D; Gudelj L
Psychiatr Danub; 2010 Mar; 22(1):14-27. PubMed ID: 20305586
[TBL] [Abstract][Full Text] [Related]
9. Absent response to niacin skin patch is specific to schizophrenia and independent of smoking.
Liu CM; Chang SS; Liao SC; Hwang TJ; Shieh MH; Liu SK; Chen WJ; Hwu HG
Psychiatry Res; 2007 Aug; 152(2-3):181-7. PubMed ID: 17459487
[TBL] [Abstract][Full Text] [Related]
10. Niacin skin flushing in schizophrenic and depressed patients and healthy controls.
Bosveld-van Haandel L; Knegtering R; Kluiter H; van den Bosch RJ
Psychiatry Res; 2006 Aug; 143(2-3):303-6. PubMed ID: 16837062
[TBL] [Abstract][Full Text] [Related]
11. [The evaluation of well-being of schizophrenic or depressed patients with Bradley's questionnaire: a pilot study].
Jarema M; Szafrański T; Waszkiewicz-Białek E; Marciniak A; Rosłaniec D
Psychiatr Pol; 1997; 31(1):87-96. PubMed ID: 9527658
[TBL] [Abstract][Full Text] [Related]
12. Frequency and differential diagnosis of depressive syndromes in schizophrenia.
Martin RL; Cloninger CR; Guze SB; Clayton PJ
J Clin Psychiatry; 1985 Nov; 46(11 Pt 2):9-13. PubMed ID: 2865255
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of cognitive and motor slowing in the Digit Symbol Test (DST): differences between depression and schizophrenia.
van Hoof JJ; Jogems-Kosterman BJ; Sabbe BG; Zitman FG; Hulstijn W
J Psychiatr Res; 1998; 32(2):99-103. PubMed ID: 9694005
[TBL] [Abstract][Full Text] [Related]
14. [The evaluation of subjective quality of life in patients with schizophrenia or depression].
Jarema M; Konieczyńska Z; Główczak M; Szaniawska A; Meder J; Jakubiak A
Psychiatr Pol; 1995; 29(5):641-53. PubMed ID: 8577905
[TBL] [Abstract][Full Text] [Related]
15. [Usefulness of standardized psychometric scales (BPRS, HDS)in the evaluation of schizophrenic symptoms (preliminary report)].
Linka M; Rybakowski J
Psychiatr Pol; 1990; 24(1):15-22. PubMed ID: 2284354
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive disorders in endogenous psychoses].
Plaum E; Duhm E
Psychiatr Neurol Med Psychol (Leipz); 1985 Jan; 37(1):22-9. PubMed ID: 3983290
[TBL] [Abstract][Full Text] [Related]
17. [The dexamethasone suppression test in schizophrenia and endogenous depression].
Strzelecka I; Matkowski K; Linka M; Kanarkowski R; Kretowicz W; Chmielewska Z; Rybakowski J
Psychiatr Pol; 1988; 22(1):1-7. PubMed ID: 3406212
[No Abstract] [Full Text] [Related]
18. [The P 300 potential in schizophrenia].
Laurent A; Garcia-Larrea L; Dalery J; Terra JL; D'Amato T; Marie-Cardine M; Mauguière F
Encephale; 1993; 19(3):221-7. PubMed ID: 8275907
[TBL] [Abstract][Full Text] [Related]
19. The 2-mg dexamethasone suppression test in differentiating major depression with psychosis from schizophrenia.
Clower CG
J Clin Psychopharmacol; 1986 Dec; 6(6):363-5. PubMed ID: 3805330
[TBL] [Abstract][Full Text] [Related]
20. The dexamethasone suppression test in schizophrenia.
Sawyer J; Jeffries JJ
J Clin Psychiatry; 1984 Sep; 45(9):399-402. PubMed ID: 6469927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
